| P50 | author | Gareth Evans | Q29642643 |
| | Miriam J Smith | Q58217715 |
| | Ype Elgersma | Q64966727 |
| | Larry S Sherman | Q92601209 |
| P2093 | author name string | Eric Legius | |
| | Aaron Schindeler | |
| | Marco Giovannini | |
| | Scott Plotkin | |
| | Rosalie E Ferner | |
| | Brigitte Widemann | |
| | Alison Lloyd | |
| | Nicole J Ullrich | |
| | Karlyne M Reilly | |
| | Annette Bakker | |
| | Ludwine M Messiaen | |
| P2860 | cites work | The spectrum of SWI/SNF mutations, ubiquitous in human cancers | Q21090801 |
| | A neuronal function of the tumor suppressor protein merlin | Q26830181 |
| | Prognostic significance of Tks5 expression in gliomas. | Q30010180 |
| | Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer | Q30193662 |
| | The NF1 somatic mutational landscape in sporadic human cancers | Q33823452 |
| | The development of cutaneous neurofibromas | Q34760769 |
| | Expanding the mutational spectrum of LZTR1 in schwannomatosis | Q35722195 |
| | Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models. | Q38636749 |
| | Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT). | Q38808993 |
| | Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. | Q39186096 |
| | Genetic and epigenetic alterations in meningiomas | Q39320009 |
| | Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development. | Q41464099 |
| | HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. | Q41722445 |
| | Incidence and mortality of neurofibromatosis: a total population study in Finland | Q44390105 |
| | Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. | Q45951553 |
| | Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848. | Q47182839 |
| | Dietary intervention rescues myopathy associated with neurofibromatosis type 1. | Q47307112 |
| | Impaired engagement of the ventral attention system in neurofibromatosis type 1. | Q48236073 |
| | The Characteristics of 76 Atypical Neurofibromas as Precursors to Neurofibromatosis 1 Associated Malignant Peripheral nerve Sheath Tumors | Q48510261 |
| | Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models | Q50026654 |
| | The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent | Q50069686 |
| | The neural basis of deficient response inhibition in children with neurofibromatosis type 1: Evidence from a functional MRI study. | Q52093375 |
| | Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA. | Q52664564 |
| | Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis. | Q53316010 |
| | Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision. | Q55457767 |
| | Schwannomatosis: a genetic and epidemiological study | Q57266316 |
| | Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service | Q57266646 |
| | Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation | Q88778968 |
| | Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas | Q90146619 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurofibromatosis type II | Q1935832 |
| | SCHWANNOMATOSIS | Q57772130 |
| P304 | page(s) | 1098-1106 | |
| P577 | publication date | 2019-03-25 | |
| P1433 | published in | American Journal of Medical Genetics | Q4744254 |
| P1476 | title | From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis | |
| P478 | volume | 179 | |